HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.

Abstract
Dopamine D3 receptor antagonists and partial agonists have been shown to modulate drug-seeking effects induced by cocaine and other abused substances. Compound 6 [PG01037, (N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-trans-but-2-enyl)-4-pyridine-2-ylbenzamide)] and related analogues are currently being evaluated in animal models of drug addiction. In these studies, a discrepancy between in vitro binding affinity, in vivo occupancy, and behavioral potency has been observed. The purpose of this study was to examine (1) modifications of the 2-pyridylphenyl moiety of 6 and (2) hydroxyl, acetyl, and cyclopropyl substitutions on the butylamide linking chain systematically coupled with 2-fluorenylamide or 2-pyridylphenylamide and 2-methoxy- or 2,3-dichloro-substituted phenylpiperazines to measure the impact on binding affinity, D2/D3 selectivity, lipophilicity, and function. In general, these modifications were well tolerated at the human dopamine D3 (hD3) receptor (Ki = 1-5 nM) as measured in competition binding assays. Several analogues showed >100-fold selectivity for dopamine D3 over D2 and D4 receptors. In addition, while all the derivatives with an olefinic linker were antagonists, in quinpirole-stimulated mitogenesis at hD3 receptors, several of the hydroxybutyl-linked analogues (16, 17, 21) showed partial agonist activity. Finally, several structural modifications reduced lipophilicities while retaining the desired binding profile.
AuthorsPeter Grundt, Katherine M Prevatt, Jianjing Cao, Michelle Taylor, Christina Z Floresca, Ji-Kyung Choi, Bruce G Jenkins, Robert R Luedtke, Amy Hauck Newman
JournalJournal of medicinal chemistry (J Med Chem) Vol. 50 Issue 17 Pg. 4135-46 (Aug 23 2007) ISSN: 0022-2623 [Print] United States
PMID17672446 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • Amides
  • Benzamides
  • Ligands
  • N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-pyridine-2-ylbenzamide
  • Piperazines
  • Pyridines
  • Receptors, Dopamine D3
Topics
  • Amides (chemical synthesis, chemistry, pharmacology)
  • Animals
  • Benzamides (chemistry, pharmacokinetics)
  • Binding, Competitive
  • Brain (metabolism)
  • Cell Line
  • Humans
  • Ligands
  • Magnetic Resonance Imaging
  • Mitosis (drug effects)
  • Piperazines (chemical synthesis, chemistry, pharmacology)
  • Pyridines (chemistry, pharmacokinetics)
  • Radioligand Assay
  • Rats
  • Receptors, Dopamine D3 (agonists, antagonists & inhibitors)
  • Stereoisomerism
  • Structure-Activity Relationship
  • Substance-Related Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: